Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
Provided By GlobeNewswire
Last update: Feb 14, 2025
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three months ended December 31, 2024 and provided an update on its business.
Read more at globenewswire.comNASDAQ:EDSA (2/20/2025, 1:34:58 PM)
2.52
-0.02 (-0.79%)
Find more stocks in the Stock Screener
EDSA Latest News and Analysis
2 days ago - ChartmillWondering what's happening in today's pre-market session?Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
